SELECT COUNTRY
VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA
ALGERIA
ANGOLA
ARGENTINA
AUSTRALIA
AZERBAIJAN
BAHREIN
BELGIUM
BENIN
BOLIVIA
BOTSWANA
BRAZIL
BRUNEI
BURKINA FASO
CAMEROON
CANADA
CENTRAL AFRICAN REPUBLIC
CHAD
CHILE
CHINA
COLOMBIA
COTE D’IVOIRE
CZECH REPUBLIC
DOMINICAN REPUBLIC
DRC
ECUADOR
EGYPT
EQUATORIAL GUINEA
ETHIOPIA
FINLAND
FRANCE
GABON
GHANA
GREENLAND
GUINEA
GUYANA
HUNGARY
ICELAND
INDIA
INDONESIA
IRAN
IRAQ
ITALY
JAPAN
KAZAKHSTAN
KENYA
KUWAIT
LESOTHO
LIBERIA
MADAGASCAR
MALAWI
MALAYSIA
MALI
MAURITANIE
MEXICO
MONGOLIA
MOROCCO
MOZAMBIQUE
NAMIBIA
NETHERLANDS
NICARAGUA
NIGER
NIGERIA
NORWAY
PANAMA
PAPUA NEW GUINEA
PARAGUAY
PERU
PHILIPPINES
POLAND
QATAR
REPUBLIC OF CONGO
RUSSIA
RWANDA
SAUDI ARABIA
SENEGAL
SIERRA LEONE
SINGAPORE
SLOVENIA
SOMALI
SOUTH AFRICA
SOUTH KOREA
SPAIN
SUDAN
SWEDEN
TAIWAN
TANZANIA
THAILAND
TOGO
TRINDAD & TOBAGO
TURKEY
TURKMENISTAN
UAE
UGANDA
UKRAINE
UNITED KINGDOM
UNITED STATES
VENEZUELA
VIETNAM
ZAMBIA
ZIMBABWE
TURKEY: LATEST INTERVIEWS MORE INTERVIEWS
Ekol provides international freight, warehousing, distribution, foreign trade, customs, and supply-chain management services across Europe.
AstraZeneca Turkey provides an overview of its Turkish operations and opinions on the market.
Acibadem University is a private university founded in 2007, belonging to the Acibadem Healthcare Group. Professor Dr Kocagöz is a microbiology and infectious disease specialist.
ERA Pharma Solutions is a contract research organization (CRO) established in 2010 to provide drug discovery, development and lifecycle management services for the pharmaceutical industry.
TURKEY: LATEST ARTICLES
Turkey Pharmaceuticals: Bringing All Actors Together
June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.
Turkey’s Nascent Biopharma Sector: The Transition to Large Molecules
May 15, 2020
The Turkish pharma industry is on the eve of a rebirth as it seeks to grow a biopharma component.
Impact of COVID-19 in Turkey
May 14, 2020
Efforts to stave off the crisis are consequential in shaping future health and welfare policy.
TURKEY: RECENTLY RELEASED PUBLICATIONS
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
MACIG 2025 - Mining in Africa Country Investment Guide
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
